TRAX - Conference and earnings call announcements

SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences: 21st Annual Wells Fargo Healthcare Conference, Boston Format – Fireside chat and one-on-one investor meetingsDate and Time – Wednesday, Sept. 9, 2026 at 9:30am ET / 6:30am PT Citi's 2026 Biopharma Back to School Conference, New York City Format – One-on-one investor meetingsDate and Time – Thursday, Sept. 10, 2026 Morgan

SAN DIEGO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that Daniel Faga, president and chief executive officer, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: 2026 Jefferies Global Healthcare Conference, New York Format – Presentation and one-on-one investor meetingsDate and Time – Wednesday, June 3, 2026 at 12:15pm ET / 9:15am PT Leerink Partners Therapeutics Forum, Boston Format – One-on-one i